Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580047 · ClinicalTrials.gov registry record · NA
Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT00580047: Completed NA study, sponsored by University of Nebraska.
NCT00580047 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00580047, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The study is designed to look at the effect of different bone treatment plans on bone loss after kidney or kidney/pancreas transplant.
Primary Outcome
Posterior Anterior (PA) spine bone density was measured by dual energy x-ray absorptiometry (DXA) at baseline and 24 months post transplant. The percentage change in the PA spine bone density was then compared from baseline to 24 months post transplant.
Interventions
- DRUG Zoledronic Acid
- DRUG Alendronate
- COMBINATION_PRODUCT Calcium with vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2003-12-01 |
| Est. Completion | 2014-07-29 |
| Phase | NA |
What the finished NCT00580047 record still lists
NCT00580047 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Zoledronic Acid is the first listed.
NCT00580047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00580047 about?
NCT00580047 is a clinical study titled "Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants". The study is designed to look at the effect of different bone treatment plans on bone loss after kidney or kidney/pancreas transplant.
What is the current status of trial NCT00580047?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2003-12-01. Estimated completion is 2014-07-29.
What interventions are being tested in trial NCT00580047?
The interventions under investigation include: Zoledronic Acid (DRUG), Alendronate (DRUG), Calcium with vitamin D (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT00580047?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00580047's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI